Trial Profile
Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Alteplase (Primary) ; Alteplase (Primary) ; Urokinase (Primary)
- Indications Embolism and thrombosis; Haemorrhage; Stroke
- Focus Therapeutic Use
- Acronyms MR CLEAN
- 11 Jan 2022 Results of MR CLEAN Registry Substudy assessing clinical and safety outcomes of patients with acute ischemic stroke (AIS) and active cancer after endovascular treatment published in the Neurology
- 14 Oct 2021 Results assessing whether endovascular therapy plus usual care is cost-effective in comparison to usual care alone in acute ischemic stroke patients, published in the Stroke.
- 20 Sep 2021 Results (n=1161) evaluating the associations of systolic BP in the first 6 hours following EVT with functional outcome and the occurrence of symptomatic intracranial hemorrhage, published in the Stroke